Showing results (31-40 of 349) with videos related to

Sort By:
Pageof 35
American Journal of Respiratory and Critical Care Medicine|July 7, 2007
IL13 promoter polymorphism 1112C/T modulates the adverse effect of tobacco smoking on lung functionAlireza Sadeghnejad, Deborah A Meyers, Matteo Bottai, et al.
BMC Medical Genetics|October 28, 2004
CLC-2 single nucleotide polymorphisms (SNPs) as potential modifiers of cystic fibrosis disease severityCarol J Blaisdell, Timothy D Howard, Augustus Stern, et al.
Pharmacogenetics and Genomics|July 16, 2008
A polymorphism of G-protein coupled receptor kinase5 alters agonist-promoted desensitization of beta2-adrenergic receptorsWayne C H Wang, Kathryn A Mihlbachler, Eugene R Bleecker, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 3, 2008
Assessing productivity loss and activity impairment in severe or difficult-to-treat asthmaHubert Chen, Paul D Blanc, Mary L Hayden, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 25, 2021
German regional variation of acute and high oral corticosteroid use for asthmaCassandra Nan, Olaf Schmidt, Robert Lindner, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 23, 2020
Tiotropium Respimat Efficacy and Safety in Asthma: Relationship to AgeDennis E Doherty, Eugene R Bleecker, Petra Moroni-Zentgraf, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 10, 2010
Subacute lack of asthma control and acute asthma exacerbation history as predictors of subsequent acute asthma exacerbations: evidence from managed care dataRichard D O'Connor, Eugene R Bleecker, Aidan Long, et al.
The Journal of Allergy and Clinical Immunology|November 9, 2005
Severity assessment in asthma: An evolving conceptMary K Miller, Charles Johnson, Dave P Miller, et al.
Clinics in Chest Medicine|August 30, 2012
Genetics of asthma susceptibility and severityRebecca E Slager, Gregory A Hawkins, Xingnan Li, et al.
Lancet (London, England)|December 25, 2007
Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studiesEugene R Bleecker, Dirkje S Postma, Rachael M Lawrance, et al.
Pageof 35